These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25101884)

  • 41. CFTR protein repair therapy in cystic fibrosis.
    Quintana-Gallego E; Delgado-Pecellín I; Calero Acuña C
    Arch Bronconeumol; 2014 Apr; 50(4):146-50. PubMed ID: 24095197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ivacaftor potentiation of multiple CFTR channels with gating mutations.
    Yu H; Burton B; Huang CJ; Worley J; Cao D; Johnson JP; Urrutia A; Joubran J; Seepersaud S; Sussky K; Hoffman BJ; Van Goor F
    J Cyst Fibros; 2012 May; 11(3):237-45. PubMed ID: 22293084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination CFTR modulator therapy in children and adults with cystic fibrosis.
    Guimbellot JS; Taylor-Cousar JL
    Lancet Respir Med; 2021 Jul; 9(7):677-679. PubMed ID: 33965001
    [No Abstract]   [Full Text] [Related]  

  • 44. Orphan cystic fibrosis drugs find sister diseases.
    Dolgin E
    Nat Med; 2011 Apr; 17(4):397. PubMed ID: 21475214
    [No Abstract]   [Full Text] [Related]  

  • 45. [Causal therapy is available].
    Meißner T
    MMW Fortschr Med; 2016 Jun; 158(12):74. PubMed ID: 27324018
    [No Abstract]   [Full Text] [Related]  

  • 46. The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model.
    Gentzsch M; Cholon DM; Quinney NL; Boyles SE; Martino MEB; Ribeiro CMP
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30287473
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation.
    De Boeck K; Munck A; Walker S; Faro A; Hiatt P; Gilmartin G; Higgins M
    J Cyst Fibros; 2014 Dec; 13(6):674-80. PubMed ID: 25266159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lumacaftor/ivacaftor (Orkambi) for cystic fibrosis.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):41-2. PubMed ID: 27027688
    [No Abstract]   [Full Text] [Related]  

  • 49. Update in cystic fibrosis 2013.
    Jain M; Goss CH
    Am J Respir Crit Care Med; 2014 May; 189(10):1181-6. PubMed ID: 24832742
    [No Abstract]   [Full Text] [Related]  

  • 50. CT imaging of pediatric patients with cystic fibrosis on ivacaftor therapy.
    Hayes D; Long FR; McCoy KS; Sheikh SI
    Lung; 2014 Oct; 192(5):823-4. PubMed ID: 25099273
    [No Abstract]   [Full Text] [Related]  

  • 51. Personalized Drug Therapy in Cystic Fibrosis: From Fiction to Reality.
    de Lima Marson FA; Bertuzzo CS; Ribeiro JD
    Curr Drug Targets; 2015; 16(9):1007-17. PubMed ID: 25438972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cystic fibrosis in the era of genomic medicine.
    Milla CE
    Curr Opin Pediatr; 2013 Jun; 25(3):323-8. PubMed ID: 23652683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update in Cystic Fibrosis 2014.
    Ong T; Ramsey BW
    Am J Respir Crit Care Med; 2015 Sep; 192(6):669-75. PubMed ID: 26371812
    [No Abstract]   [Full Text] [Related]  

  • 54. Promising new era dawns for cystic fibrosis treatment.
    Corbyn Z
    Lancet; 2012 Apr; 379(9825):1475-6. PubMed ID: 22530244
    [No Abstract]   [Full Text] [Related]  

  • 55. New cystic fibrosis drug paves the way for orphan diseases.
    Cooney D
    Lancet Respir Med; 2013 Apr; 1(2):104. PubMed ID: 24429084
    [No Abstract]   [Full Text] [Related]  

  • 56. Radical new treatments for cystic fibrosis.
    Arch Dis Child; 2015 Aug; 100(8):727. PubMed ID: 26078470
    [No Abstract]   [Full Text] [Related]  

  • 57. Remarkable progress toward new treatments for cystic fibrosis.
    Eldredge LC; Ramsey BW
    Lancet Respir Med; 2014 Dec; 2(12):962-4. PubMed ID: 25466347
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cystic Fibrosis: toward a genetic treatment; Clostridium difficile versus Clostridium difficile].
    Nau JY
    Rev Med Suisse; 2015 May; 11(476):1210-1. PubMed ID: 26182641
    [No Abstract]   [Full Text] [Related]  

  • 59. Suppressing 'nonsense' in cystic fibrosis.
    Hinzpeter A; Sermet-Gaudelus I; Sheppard DN
    J Physiol; 2020 Feb; 598(3):429-430. PubMed ID: 31869855
    [No Abstract]   [Full Text] [Related]  

  • 60. A bioassay using intestinal organoids to measure CFTR modulators in human plasma.
    Dekkers R; Vijftigschild LA; Vonk AM; Kruisselbrink E; de Winter-de Groot KM; Janssens HM; van der Ent CK; Beekman JM
    J Cyst Fibros; 2015 Mar; 14(2):178-81. PubMed ID: 25467948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.